Detalhe da pesquisa
1.
Intertwined regulation of angiogenesis and immunity by myeloid cells.
Trends Immunol
; 36(4): 240-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25770923
2.
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
NMR Biomed
; 27(11): 1361-70, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25199993
3.
Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors.
Mol Cancer Ther
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648067
4.
ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms.
Cancer Immunol Res
; 12(5): 592-613, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393969
5.
The regulatory function of SPARC in vascular biology.
Cell Mol Life Sci
; 68(19): 3165-73, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21822645
6.
SPARC regulates collagen interaction with cardiac fibroblast cell surfaces.
Am J Physiol Heart Circ Physiol
; 301(3): H841-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21666116
7.
The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells.
Cancer Immunol Res
; 9(11): 1283-1297, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426457
8.
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
Sci Transl Med
; 9(385)2017 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404866
9.
Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.
Cell Rep
; 11(4): 577-91, 2015 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892230
10.
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Cancer Res
; 74(4): 1032-44, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24346431
11.
Neutralizing murine TGFßR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.
Cancer Res
; 74(18): 4996-5007, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060520
12.
Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.
Cancer Cell
; 24(6): 687-9, 2013 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332035
13.
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFß activation.
PLoS One
; 7(2): e31384, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22348081
14.
TGF-ß and αvß6 integrin act in a common pathway to suppress pancreatic cancer progression.
Cancer Res
; 72(18): 4840-5, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22787119
15.
SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-ß1 activity.
J Cell Biol
; 193(7): 1305-19, 2011 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21708981
16.
CANCER. Tumor angiogenesis, from foe to friend.
Science
; 349(6249): 694-5, 2015 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26273044
17.
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes.
Dis Model Mech
; 3(9-10): 567-80, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616094
18.
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
Dis Model Mech
; 3(1-2): 57-72, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20007485
19.
Angiogenesis. Targeting vascular sprouts.
Science
; 344(6191): 1449-50, 2014 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970064